-
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Friday, June 20, 2025 - 5:59am | 1111A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has reignited discussions on Pharmacy Benefit Managers (...
-
Mark Cuban Floats Bold Healthcare Plan: 'Zero Premiums To Insurance Companies' With A Cash-Pay Revolution
Tuesday, June 17, 2025 - 7:21am | 892Billionaire entrepreneur Mark Cuban has proposed a bold plan to revolutionize the U.S. healthcare system, eliminating traditional insurance premiums and introducing transparent pricing. What Happened: Cuban’s recent proposal, posted on social media platform X, comes amid growing frustration...
-
Diplomat Pharmacy Has 'Substantial Doubt' It Can Continue Operations
Tuesday, November 12, 2019 - 3:11pm | 421Shares of Diplomat Pharmacy, Inc. (NYSE: DPLO), a Flint, Michigan-based independent provider of specialty pharmacy and infusion services, plummeted more than 50% Tuesday after the company warned investors it faces an existential threat. What Happened Diplomat reported third-quarter...
-
Analysts React To Diplomat Pharmacy's Q4 Earnings, Concerning Guidance
Monday, March 18, 2019 - 3:18pm | 530Diplomat Pharmacy Inc (NYSE: DPLO) on Friday reported its previously delayed fourth-quarter earnings miss and concerning guidance, which sent the stock tumbling nearly 14 percent. The Analysts Mizuho Securities' Ann Hynes maintains a Neutral rating on Diplomat Pharmacy with a price target...
-
Predicted Gross Margin Pressure, EPS Erosion Turn Bernstein Bearish On Express Scripts
Thursday, February 1, 2018 - 2:05pm | 422Shares of Express Scripts Holding Company (NASDAQ: ESRX) have risen more than 30 percent since Thanksgiving 2017, mostly due to expectations of earnings improvements stemming from U.S. tax legislation. But the gains are now "overdone," according to Bernstein. The Analyst Bernstein...
-
Leerink Suggests 4 Health Care Plays On Recent Weakness
Wednesday, January 31, 2018 - 11:46am | 669Health care stocks for the most part traded notably lower Tuesday in reaction to the formation of a new not-for-profit company spearheaded by Amazon.com, Inc. (NASDAQ: AMZN)'s Jeff Bezos, JPMorgan Chase & Co. (NYSE: JPM)'s Jamie Dimon and Berkshire Hathaway Inc. (NYSE: BRK.A) (...
-
Needham Sees A Healthy Risk-Reward For CVS Health
Friday, November 10, 2017 - 1:29pm | 430CVS Health Corp (NYSE: CVS)'s proposed acquisition of health insurer Aetna Inc (NYSE: AET) could be seen as a move to better defend itself should Amazon.com, Inc. (NASDAQ: AMZN) flex its muscles and enter the drug space. The Analyst Needham's Kevin Caliendo. The Rating Caliendo upgraded...
-
PBM Space Gets Cozier With Anthem's New In-House Service, Amazon's Rumored Entrance
Wednesday, October 18, 2017 - 11:06am | 341Anthem Inc (NYSE: ANTM) announced Wednesday its plans to launch an internal pharmacy-benefit manager at the 2019 expiration of its Express Scripts Holding Company (NASDAQ: ESRX) contract. The new unit, IngenioRx, will debut in 2020 through CVS Health Corp (NYSE: CVS) and is expected to yield more...
-
Why Amazon Needs To Partner With Or Buy A Pharmacy Benefit Manager
Thursday, September 28, 2017 - 3:14pm | 488Amazon.com, Inc. (NASDAQ: AMZN) is expected to take a big step into pharmacy ━ because it can. “We think that Amazon will enter the retail pharmacy industry, in large part because this is a large and disruptable market,” Bernstein analyst Lance Wilkes said in a Thursday note. But its...
-
Chin Up, Rite Aid Holders: This Deal Is Probably Better Than No Deal At All
Friday, June 30, 2017 - 12:06pm | 391Walgreens Boots Alliance Inc (NASDAQ: WBA) proposed back in 2015 to fully acquire Rite Aid Corporation (NYSE: RAD) in a deal that would value the smaller pharmacy retail chain at $9 per share. But regulatory concerns are part of the reason why the merger agreement is officially off the table....